Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Santhera regains fipamezole rights

Jan. 24, 2012

Sosei and Ceolia Pharma sign technical alliance agreement

Jan. 24, 2012

La Jolla Pharmaceutical acquires rights to first-in-class galectin-3 inhibitor

Jan. 24, 2012

New Japanese approval of controlled-release paroxetine product

Jan. 20, 2012

Vivalis and Sanofi Pasteur extend collaboration

Jan. 20, 2012

XOMA acquires U.S. rights to Servier franchise

Jan. 19, 2012

Joint research agreement targets novel biofocused anticancer therapies

Jan. 19, 2012

Constellation Pharmaceuticals enters collaboration

Jan. 19, 2012

Ventana to develop companion diagnostic test for Bayer

Jan. 17, 2012

LoneStar Heart acquires exclusive worldwide license

Jan. 17, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...